S&P 500   4,604.37
DOW   36,247.87
QQQ   392.17
MarketBeat Week in Review – 12/4 - 12/8
Trading Experts Call It “The Perfect Tesla Trade” (Ad)
Dozens of animals taken from Virginia roadside zoo as part of investigation
Military-themed brewery wants to open in a big Navy town. An ex-SEAL is getting in the way
Trading Experts Call It “The Perfect Tesla Trade” (Ad)
Cows in Rotterdam harbor, seedlings on rafts in India; are floating farms the future?
Agriculture gets its day at COP28, but experts see big barriers to cutting emissions
Trading Experts Call It “The Perfect Tesla Trade” (Ad)
Shohei Ohtani joins big-money club with massive contract with Los Angeles Dodgers
Consumer product agency issues warning on small magnetic balls linked to deaths
S&P 500   4,604.37
DOW   36,247.87
QQQ   392.17
MarketBeat Week in Review – 12/4 - 12/8
Trading Experts Call It “The Perfect Tesla Trade” (Ad)
Dozens of animals taken from Virginia roadside zoo as part of investigation
Military-themed brewery wants to open in a big Navy town. An ex-SEAL is getting in the way
Trading Experts Call It “The Perfect Tesla Trade” (Ad)
Cows in Rotterdam harbor, seedlings on rafts in India; are floating farms the future?
Agriculture gets its day at COP28, but experts see big barriers to cutting emissions
Trading Experts Call It “The Perfect Tesla Trade” (Ad)
Shohei Ohtani joins big-money club with massive contract with Los Angeles Dodgers
Consumer product agency issues warning on small magnetic balls linked to deaths
S&P 500   4,604.37
DOW   36,247.87
QQQ   392.17
MarketBeat Week in Review – 12/4 - 12/8
Trading Experts Call It “The Perfect Tesla Trade” (Ad)
Dozens of animals taken from Virginia roadside zoo as part of investigation
Military-themed brewery wants to open in a big Navy town. An ex-SEAL is getting in the way
Trading Experts Call It “The Perfect Tesla Trade” (Ad)
Cows in Rotterdam harbor, seedlings on rafts in India; are floating farms the future?
Agriculture gets its day at COP28, but experts see big barriers to cutting emissions
Trading Experts Call It “The Perfect Tesla Trade” (Ad)
Shohei Ohtani joins big-money club with massive contract with Los Angeles Dodgers
Consumer product agency issues warning on small magnetic balls linked to deaths
S&P 500   4,604.37
DOW   36,247.87
QQQ   392.17
MarketBeat Week in Review – 12/4 - 12/8
Trading Experts Call It “The Perfect Tesla Trade” (Ad)
Dozens of animals taken from Virginia roadside zoo as part of investigation
Military-themed brewery wants to open in a big Navy town. An ex-SEAL is getting in the way
Trading Experts Call It “The Perfect Tesla Trade” (Ad)
Cows in Rotterdam harbor, seedlings on rafts in India; are floating farms the future?
Agriculture gets its day at COP28, but experts see big barriers to cutting emissions
Trading Experts Call It “The Perfect Tesla Trade” (Ad)
Shohei Ohtani joins big-money club with massive contract with Los Angeles Dodgers
Consumer product agency issues warning on small magnetic balls linked to deaths

Penumbra Stock Price, News & Analysis (NYSE:PEN)

$224.04
+0.85 (+0.38%)
(As of 12/8/2023 ET)
Compare
Today's Range
$221.14
$224.73
50-Day Range
$181.44
$238.35
52-Week Range
$180.93
$348.67
Volume
279,165 shs
Average Volume
442,441 shs
Market Capitalization
$8.65 billion
P/E Ratio
217.52
Dividend Yield
N/A
Price Target
$317.25

Penumbra MarketRank™ Stock Analysis

Analyst Rating
Moderate Buy
2.83 Rating Score
Upside/​Downside
41.6% Upside
$317.25 Price Target
Short Interest
Bearish
6.48% of Shares Sold Short
Dividend Strength
N/A
Sustainability
-1.33
Upright™ Environmental Score
News Sentiment
0.72mentions of Penumbra in the last 14 days
Based on 7 Articles This Week
Insider Trading
Selling Shares
$5.46 M Sold Last Quarter
Proj. Earnings Growth
42.16%
From $2.04 to $2.90 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.43 out of 5 stars

Medical Sector

164th out of 932 stocks

Surgical & Medical Instruments Industry

26th out of 93 stocks


PEN stock logo

About Penumbra Stock (NYSE:PEN)

Penumbra, Inc., together with its subsidiairies, designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers aspiration based thrombectomy systems and accessory devices, including revascularization device for mechanical thrombectomy, such as Penumbra System under the Penumbra RED, JET, ACE, 3D Revascularization Device, and Penumbra ENGINE brands, as well as components and accessories; neurovascular embolization coiling systems to treat patients with various sizes of aneurysms and other neurovascular lesions under the Penumbra Coil 400, POD400, PAC400, and Penumbra SMART Coil brand names; and neurovascular access systems designed to provide intracranial access for use in a range of neurovascular therapies under the Neuron, Neuron MAX, Select, BENCHMARK, BMX96, DDC, SENDit, and PX SLIM brands. It also provides neurosurgical aspiration tools for the removal of tissue and fluids under the Artemis Neuro Evacuation Device brand; aspiration-based thrombectomy systems for vascular applications under the Indigo System, Lightning, and CAT RX brand; and detachable embolic coil systems for peripheral embolization under the Ruby Coil and Ruby LP brand names. In addition, the company offers microcatheter for the delivery of detachable coils and occlusion devices under the LANTERN brand; and POD (Penumbra Occlusion Device) brand, as well as immersive 3D computer-based technology platform under the Real Immersive System brand; and a complementary device for use with Ruby Coil and POD for vessel occlusion under the Packing Coil and Packing Coil LP brands. The company sells its products through direct sales organizations and distributors. Penumbra, Inc. was incorporated in 2004 and is headquartered in Alameda, California.

PEN Stock Price History

PEN Stock News Headlines

Analyzing BrainsWay (NASDAQ:BWAY) & Penumbra (NYSE:PEN)
How to Invest Early In the Next Potential Breakthrough Nerve-Sensing Technology
Autonomix is preparing a public listing as they develop technology to potentially detect and treat a range of nervous system disorders with much greater visibility than available today. Now, their management team sees a potentially untapped $100B market opportunity.* *Disclosure: This is a paid advertisement for Autonomix’s Regulation A+ Offering. Please read the offering circular at invest.autonomix.com
Trading Experts Call It “The Perfect Tesla Trade”
Thanks to a new discovery linked to shares of Tesla, regular folks can now target gains of 100% or more in six days or less. New research shows it’s happened 23 different times this year. The next trade is scheduled for this Thursday.
Penumbra GAAP EPS of $0.23
Penumbra: Q3 Earnings Snapshot
Here's what Wall Street expects from Penumbra's earnings report
Penumbra (PEN) Declined on Weak Second Quarter Earnings
See More Headlines
Receive PEN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Penumbra and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
11/02/2023
Today
12/10/2023
Fiscal Year End
12/31/2023
Next Earnings (Estimated)
2/22/2024

Industry, Sector and Symbol

Industry
Surgical & medical instruments
Sub-Industry
N/A
Sector
Medical
Employees
3,900
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$317.25
High Stock Price Target
$376.00
Low Stock Price Target
$240.00
Potential Upside/Downside
+41.6%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.83
Research Coverage
12 Analysts

Profitability

Net Income
$-2,000,000.00
Pretax Margin
4.89%

Debt

Sales & Book Value

Annual Sales
$847.13 million
Cash Flow
$0.81 per share
Book Value
$26.30 per share

Miscellaneous

Free Float
36,550,000
Market Cap
$8.65 billion
Optionable
Optionable
Beta
0.62
The 10 Best AI Stocks to Own in 2024 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

Key Executives















PEN Stock Analysis - Frequently Asked Questions

Should I buy or sell Penumbra stock right now?

12 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Penumbra in the last twelve months. There are currently 2 hold ratings and 10 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "moderate buy" PEN shares.
View PEN analyst ratings
or view top-rated stocks.

What is Penumbra's stock price target for 2024?

12 Wall Street research analysts have issued 12 month target prices for Penumbra's shares. Their PEN share price targets range from $240.00 to $376.00. On average, they expect the company's share price to reach $317.25 in the next twelve months. This suggests a possible upside of 41.6% from the stock's current price.
View analysts price targets for PEN
or view top-rated stocks among Wall Street analysts.

How have PEN shares performed in 2023?

Penumbra's stock was trading at $222.46 on January 1st, 2023. Since then, PEN shares have increased by 0.7% and is now trading at $224.04.
View the best growth stocks for 2023 here
.

When is Penumbra's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, February 22nd 2024.
View our PEN earnings forecast
.

How were Penumbra's earnings last quarter?

Penumbra, Inc. (NYSE:PEN) released its earnings results on Thursday, November, 2nd. The company reported $0.67 EPS for the quarter, beating the consensus estimate of $0.46 by $0.21. The firm earned $270.95 million during the quarter, compared to the consensus estimate of $266.02 million. Penumbra had a net margin of 4.08% and a trailing twelve-month return on equity of 5.54%.

What is Adam Elsesser's approval rating as Penumbra's CEO?

57 employees have rated Penumbra Chief Executive Officer Adam Elsesser on Glassdoor.com. Adam Elsesser has an approval rating of 88% among the company's employees.

What other stocks do shareholders of Penumbra own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Penumbra investors own include NVIDIA (NVDA), Intuitive Surgical (ISRG), AbbVie (ABBV), Tesla (TSLA), Alibaba Group (BABA), Johnson & Johnson (JNJ), Netflix (NFLX), UnitedHealth Group (UNH), Boeing (BA) and DexCom (DXCM).

Who are Penumbra's major shareholders?

Penumbra's stock is owned by a number of retail and institutional investors. Top institutional investors include FMR LLC (13.00%), Clearbridge Investments LLC (2.35%), Baillie Gifford & Co. (1.76%), William Blair Investment Management LLC (1.70%), Invesco Ltd. (1.43%) and Rock Springs Capital Management LP (1.31%). Insiders that own company stock include Adam Elsesser, Arani Bose, Bridget O'rourke, Don W Kassing, Harpreet Grewal, James Robert Pray, Johanna Roberts, Surbhi Sarna and Thomas Wilder.
View institutional ownership trends
.

How do I buy shares of Penumbra?

Shares of PEN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

This page (NYSE:PEN) was last updated on 12/10/2023 by MarketBeat.com Staff

My Account -